endocrinology
Obesity

Semaglutide in PBS sights as a weekly injection for weight loss

Obese patients could potentially be given PBS-subsidised access to lifelong therapy with weekly injections of the GLP-1 agonist semaglutide in nurse-led or GP-led models of care, according to scenarios discussed by the Pharmaceutical Benefits Advisory Committee (PBAC). The drug is currently available on the PBS for treatment of people with type 2 diabetes, but with ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic